1. |
张德恒, 孙辉, 崔俊生, 等. 长期补碘后甲状腺疾病的变迁 [J]. 中国实用外科杂志, 1998, 18(5): 277278.
|
2. |
Ronald A.D, Ricardo VL, Philipp UH, et al. Pathology and Genetics of Tumors of Endocrine Organs: WHO Classification of Tumors [M]. IARC Press, Lyon: 2004: 5191.
|
3. |
Kreicbergs A, Brostrm LA, Cewrien G, et al. Cellular DNA content in human osteosarcoma: aspects on diagnosis and prognosis [J]. Cancer, 1982, 50(11): 24762481.
|
4. |
De BB, Mclean E, Andersson M, et al. Iodine deficiency in 2007: global progress since 2003 [J]. Food Nutr Bull, 2008, 29(3): 195202.
|
5. |
孙团起, 边建超, 朱晓丽, 等. 甲状腺乳头状癌组织中线粒体DNA含量的变化 [J]. 复旦学报(医学版), 2008, 35(5): 635640.
|
6. |
LaytragoonLewin N, Chen F, Castro J, et al. DNA content and methylation of p16, DAPK and rassf1a gene in tumour and distant, normal mucosal tissue of head and neck squamous cell carcinoma patients [J]. Anticancer Res, 2010, 30(11): 46434648.
|
7. |
Nguyen HG, Ravid K. Polyploidy: mechanisms and cancer promotion in hematopoietic and other cells [J]. Adv Exp Med Biol, 2010, 676: 105122.
|
8. |
辛波, 肖光, 张德恒, 等. 长期补碘后地方性甲状腺肿246例流式细胞分析 [J]. 中国实用外科杂志, 2003, 23(3): 148150.
|
9. |
Lu C, Mishra A, Zhu YJ, et al. Genomic profiling of genes contributing to metastasis in a mouse model of thyroid follicular carcinoma [J]. Am J Cancer Res, 2011, 1(1): 113.
|
10. |
Kim HY, Park WY, KE LE, et al. Comparative analysis of gene expression profiles of papillary thyroid microcarcinoma and papillary thyroid carcinoma [J]. J Cancer Res Ther, 2010, 6(4): 452457.
|
11. |
Salehian B, Liu Z. Genetic alterations in differentiated thyroid cancers [J]. Endocr Metab Immune Disord Drug Targets, 2009, 9(3): 257268.
|
12. |
Liang HS, Zhong YH, Luo ZJ, et al. Comparative analysis of protein expression in differentiated thyroid tumours: a multicentre study [J]. J Int Med Res, 2009, 37(3): 927938.
|
13. |
Naryzhny SN, Lee H. Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer [J]. FEBS Lett, 2010, 584(20): 42924298.
|
14. |
Strzalka W, Ziemienowicz A. Proliferating cell nuclear antigen (PCNA): a key factor in DNA replication and cell cycle regulation [J]. Ann Bot, 2011, 107(7): 11271140.
|
15. |
宋楠萌, 桑建利, 徐恒. 增殖细胞核抗原(PCNA)的分子结构及其生物学功能研究进展 [J]. 自然科学进展, 2006, 16(10): 12011209.
|
16. |
Kohlberger P, Beneder C, Horvat R, et al. Immunohistochemical expression of laminin5 in cervical intraepithelial neoplasia [J]. Gynecol Oncol, 2003, 89(3): 391394.
|
17. |
Nordstrm B, Einhorn N, Silfverswrd C, et al. Laminin5 gamma 2 chain as an invasivity marker for uniand multifocal lesions in the lower anogenital tract [J]. Int J Gynecol Cancer, 2002, 12(1): 105109.
|
18. |
Fiorentino M, Fu L, Shi YB. Mutational analysis of the cleavage of the cancerassociated laminin receptor by stromelysin3 reveals the contribution of flanking sequences to site recognition and cleavage efficiency [J]. Int J Mol Med, 2009, 23(3): 389397.
|
19. |
Kim TH, Lee SY, Rho JH, et al. Mutant p53 (G199V)gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells [J]. Mol Cancer Res, 2009, 7(10): 16451654.
|
20. |
Gauchotte G, Philippe C, Lacomme S, et al. BRAF, p53 and SOX2 in anaplastic thyroid carcinoma: evidence for multistep carcinogenesis [J]. Pathology, 2011, 43(5): 447452.
|
21. |
Lavra L, Rinaldo C, Ulivieri A, et al. The loss of the p53 activator HIPK2 is responsible for galectin3 overexpression in well differentiated thyroid carcinomas [J]. PLoS One, 2011, 6(6): e20665.
|
22. |
Linda MR, Sanfilippo M, Vella V, et al. Reactivation of p53 mutants by prima1 in thyroid cancer cells [J]. Int J Cancer, 2011, doi: 10.1002/ijc.26228.
|
23. |
Tan A, Etit D, Bayol U, et al. Comparison of proliferating cell nuclear antigen,thyroid transcription factor1, Ki67, p63, p53 and highmolecular weight cytokeratin expressions in papillary thyroid carcinoma,follicular carcinoma, and follicular adenoma [J]. Ann Diagn Pathol, 2011, 15(2): 108116.
|
24. |
田兴松, 朱见, 丛明华, 等. 甲状腺癌组织EG1和VEGFC及p53表达及临床意义的探讨 [J]. 中华肿瘤防治杂志, 2010, 17(18): 14371440.
|
25. |
Bhowmick NA, Moses HL. Tumorstroma interactions [J]. Curr Opin Genet Dev, 2005, 15(1): 97101.
|
26. |
Giatromanolaki A, Lyberakidis G, Lyratzopoulos N, et al. Angiogenesis and angiogenic factor expression in thyroid cancer [J]. J BUON, 2010, 15(2): 357361.
|
27. |
Stabenow E, Tavares MR, Ab’saber AM, et al. Angiogenesis as an indicator of metastatic potential in papillary thyroid carcinoma [J]. Clinics (Sao Paulo, Brazil), 2005, 60(3): 233240.
|